Specialty pharma developing modified-release drug formulations.
| Date | Round | Amount |
|---|---|---|
| Oct 2024 | Funding round Develco Pharma, a Tubingen specialty pharma, received a EUR10M investment from private equity firm SHS Capital. | $10.8M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.